Semble, a UK-based healthcare technology company, has secured £12 million in a Series B funding round aimed at expanding its AI-driven solutions for healthcare professionals. Semble specialises in providing workflow automation and integration tools that enhance the efficiency of medical practices, empowering healthcare providers to spend more time focusing on patient care. Supporting over 10,000 healthcare professionals across more than 70 specialties, Semble’s platform improves the delivery of care for approximately seven million patients by streamlining operations and reducing administrative burdens.
The recent funding will enable Semble to scale its offerings, including advanced workflow automation and seamless integration solutions designed to improve connection points within the healthcare ecosystem. By enhancing operational efficiency, these advancements are set to drive measurable improvements in patient outcomes across the healthcare landscape.
“At Semble, amplifying the impact of healthcare professionals is at our core,” shared Christoph Lippuner, Semble’s CEO. “This funding will help bring Semble to even more professionals, allowing them to focus more on patient care. We’re excited to position Semble at the forefront of AI-driven solutions in healthcare.”
The Series B round was led by Mercia Ventures, Octopus Ventures, Smedvig Ventures, and Triple Point, who share Semble’s commitment to building a more connected and efficient healthcare ecosystem. With this new investment, Semble is poised to expand its impact by delivering technology that supports healthcare professionals and enhances patient care.
Semble acknowledges the vital role of customer feedback in shaping its innovations. “With your support, we’re making healthcare better, together,” the announcement states, underscoring Semble’s commitment to its users and patients alike.
For more details on this announcement, visit Semble’s blog.
